Literature DB >> 33158913

Epileptiform activity and seizures in patients with COVID-19.

Fabiane Santos de Lima1, Naoum Issa1, Kaitlin Seibert1, Jared Davis1, Richard Wlodarski1, Sara Klein1, Faten El Ammar1, Shasha Wu1, Sandra Rose1, Peter Warnke1, James Tao2.   

Abstract

Entities:  

Keywords:  EEG; MRI; epilepsy; infectious diseases

Mesh:

Substances:

Year:  2020        PMID: 33158913     DOI: 10.1136/jnnp-2020-324337

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  11 in total

1.  Non-Invasive Multimodal Neuromonitoring in Non-Critically Ill Hospitalized Adult Patients With COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Denise Battaglini; Lavienraj Premraj; Samuel Huth; Jonathon Fanning; Glenn Whitman; Rakesh C Arora; Judith Bellapart; Diego Bastos Porto; Fabio Silvio Taccone; Jacky Y Suen; Gianluigi Li Bassi; John F Fraser; Rafael Badenes; Sung-Min Cho; Chiara Robba
Journal:  Front Neurol       Date:  2022-04-14       Impact factor: 4.086

Review 2.  COVID-19 associated brain/spinal cord lesions and leptomeningeal enhancement: A meta-analysis of the relationship to CSF SARS-CoV-2.

Authors:  Ariane Lewis; Rajan Jain; Jennifer Frontera; Dimitris G Placantonakis; Steven Galetta; Laura Balcer; Kara R Melmed
Journal:  J Neuroimaging       Date:  2021-06-08       Impact factor: 2.324

Review 3.  Status epilepticus and COVID-19: A systematic review.

Authors:  Fedele Dono; Bruna Nucera; Jacopo Lanzone; Giacomo Evangelista; Fabrizio Rinaldi; Rino Speranza; Serena Troisi; Lorenzo Tinti; Mirella Russo; Martina Di Pietro; Marco Onofrj; Laura Bonanni; Giovanni Assenza; Catello Vollono; Francesca Anzellotti; Francesco Brigo
Journal:  Epilepsy Behav       Date:  2021-03-17       Impact factor: 3.337

Review 4.  Cerebrospinal fluid in COVID-19: A systematic review of the literature.

Authors:  Ariane Lewis; Jennifer Frontera; Dimitris G Placantonakis; Jennifer Lighter; Steven Galetta; Laura Balcer; Kara R Melmed
Journal:  J Neurol Sci       Date:  2021-01-10       Impact factor: 3.181

5.  Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy.

Authors:  Umberto Pensato; Lorenzo Muccioli; Ilaria Cani; Damir Janigro; Pier Luigi Zinzani; Maria Guarino; Pietro Cortelli; Francesca Bisulli
Journal:  Ann Clin Transl Neurol       Date:  2021-03-29       Impact factor: 4.511

6.  Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort.

Authors:  Oscar H Del Brutto; Shasha Wu; Robertino M Mera; Aldo F Costa; Bettsy Y Recalde; Naoum P Issa
Journal:  Eur J Neurol       Date:  2021-03-01       Impact factor: 6.288

7.  Risk of hospitalization and death for COVID-19 in persons with epilepsy over a 20-month period: The EpiLink Bologna cohort, Italy.

Authors:  Lorenzo Muccioli; Corrado Zenesini; Lisa Taruffi; Laura Licchetta; Barbara Mostacci; Lidia Di Vito; Elena Pasini; Lilia Volpi; Patrizia Riguzzi; Lorenzo Ferri; Flavia Baccari; Francesco Nonino; Roberto Michelucci; Paolo Tinuper; Luca Vignatelli; Francesca Bisulli
Journal:  Epilepsia       Date:  2022-07-17       Impact factor: 6.740

8.  EEG background frequency is associated with discharge outcomes in non-ICU hospitalized patients with COVID-19.

Authors:  Kaitlin M Seibert; Wonhee Lee; Alexandra Eid; Amy E Espinal; Sara A Klein; Sumayyah K Abumurad; James X Tao; Naoum P Issa
Journal:  Front Neurol       Date:  2022-08-29       Impact factor: 4.086

Review 9.  Neurologic complications of coronavirus and other respiratory viral infections.

Authors:  Francesco Cavallieri; Johann Sellner; Marialuisa Zedde; Elena Moro
Journal:  Handb Clin Neurol       Date:  2022

Review 10.  Cerebrospinal fluid findings in patients with seizure in the setting of COVID-19: A review of the literature.

Authors:  Elizabeth Carroll; Kara R Melmed; Jennifer Frontera; Dimitris G Placantonakis; Steven Galetta; Laura Balcer; Ariane Lewis
Journal:  Seizure       Date:  2021-05-17       Impact factor: 3.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.